Abstract
No public abstract is available from the verified source records.
Daniel Ajona, Javier Gómez-Ambrosi
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries
2026
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
10.1016/s0140-6736(25)01635-6 · 2025
Body fatness and cancer--viewpoint of the IARC working group
10.1056/nejmsr1606602 · 2016
Obesity paradox in lung cancer prognosis: evolving biological insights and clinical implications
10.1016/j.jtho.2017.07.022 · 2017
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade
10.1038/s41591-018-0221-5 · 2019
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
10.1016/s1470-2045(18)30078-0 · 2018
Mechanisms linking excess adiposity and carcinogenesis promotion
2014
Relevance of body composition in phenotyping the obesities
10.1007/s11154-023-09796-3 · 2023
Obesity promotes lung carcinogenesis through airway immune dysfunction
10.1016/j.jtho.2026.104066 · 2026
Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity
10.1016/j.ccell.2016.06.005 · 2016
Caloric restriction mimetics enhance anticancer immunosurveillance
10.1016/j.ccell.2016.05.016 · 2016
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
10.1038/s43018-019-0007-9 · 2020
Fasting and fasting-mimicking conditions in the cancer immunotherapy era
10.1007/s13105-024-01020-3 · 2025
Biomarkers in lung cancer screening: achievements, promises, and challenges
10.1016/j.jtho.2018.11.023 · 2019
Visceral obesity promotes lung cancer progression-toward resolution of the obesity paradox in lung cancer
10.1016/j.jtho.2021.04.020 · 2021
No additional external references are available.